For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
The delays in Alzheimer’s research is one example of how millions of dollars in research have been stalled as NIH grapples ...
Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology at WashU Medicine, is the study ...
The anti-amyloid therapy gantenerumab lowered the chances for developing Alzheimer’s-related dementia in people at high risk for the disease, according to a small study conducted by the Knight Family ...
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression ...
Researchers followed a small group of 22 patients who had genetic mutations that cause the overproduction of amyloid in the ...
New study of longer term use of gantenerumab may indicate it can delay the onset of Alzheimer’s symptoms in people with a ...
Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.